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ABSTRACT

Gender Differences in Presenting Symptoms, Treatment, and
Outcome in Myocardial Infarction
by
Alona Dalusung-Angosta
Dr. Susan Kowalski, Examination Committee Chair
Professor of Nursing
University of Nevada, Las Vegas

The purposes of this study were to compare the presenting symptoms, treatment,
and outcome between men and women with MI. The study sample consisted of 300
patients (N = 300) who were diagnosed with MI in a county hospital in the Southwest
area of the United States.
Chest pain, shortness of breath, sweating, and left arm pain were the most
common symptoms reported by both genders. Men had more chest pain than their women
counterparts (p = .022). No significant difference was found in the cardiac enzyme levels
between both genders. Men had more Q wave changes during MI than women (p = .019).
Women suffer MI two and a half years later than men (p = .004). Oxygen, nitrates,
morphine sulfate, and heparin were the most common treatments given to men and
women. Men received more morphine sulfate (p = .013) and betablockers (p = .011)
than women in the emergency department. No significant difference was found in the
coronary diagnostic and therapeutic procedures or outcome between both genders.
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CHAPTER I

INTRODUCTION

Problem statement
Recent studies in medical and nursing literature (Micevski, 1996 and Penque, et
al., 1998) suggest that men and women present with different symptoms of myocardial
infarction (MI). Furthermore, gender differerences in the treatment of MI and mortality
outcome have been reported. However, the existing literature on gender differences in
presenting symptoms, treatment, and outcome of MI is limited. The difference in the
presenting symptoms, treatment, and outcome of MI in men and women needs to be
further evaluated so that prompt and appropriate treatment will be provided to women as
well as men experiencing an MI. This study seeks to add credibility to the existing
literature on gender differences in presenting symptoms of MI.
Background of the problem
Coronary heart disease (CHD) is the single largest killer of men and women in the
United States (American Heart Association, 1999). More men and women die from heart
disease each year than from any other cause of death including cancer, accidents,
pneumonia/influenza, and lung diseases (American Heart Association, 1999). Although
recent CHD studies have included women, more information is needed regarding this
deadly disease in relation to women.
Women in the 1990s are dying of heart disease more often than men (American
Heart Association, 1999). Recent research studies have indicated that mortality in women
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is higher than in men following MI. Marrugat et al. (1998) studied mortality differences
following MI in men and women. Their findings indicated that mortality after acute MI is
greater in women than in men. A recent study by Vaccarino et al. (1999) reported similar
findings and concluded that women have higher rates of death during hospitalization than
men following MI.
The American Heart Association (1999), the national standard source for
cardiovascular disease, describes the common symptoms of MI. It does not address
gender differences in the presenting symptoms of MI. The common symptoms of MI are
uncomfortable pressure, fullness, squeezing, or pain in the center of the chest, pain that
spreads to shoulders, neck, or arms, chest discomfort with lightheadedness, fainting,
sweating, nausea, or shortness of breath. These symptoms are presented in most
cardiovascular texts. Health care providers utilize these symptoms as guidelines for
diagnosing MI.
However, recent studies show that gender differences in presenting symptoms of
MI exist. A recent study by Penque et al. (1998) noted that more women reported
dyspnea, loss of appetite, and back pain than men. Chest pain was the common symptom
reported by either gender. This finding is consistent with the results reported by Micevski
(1996) who studied gender differences in the presenting symptoms of MI. In Micevski’s
study, chest pain was the common symptom reported by both men and women. Men
presented more often with diaphoresis and complaints of left and right arm pain; whereas,
women presented more frequently with back pain/discomfort.
Differences between men and women in their presenting symptoms may affect the
treatment and evaluation of MI. Studies have reported the presence of a gender bias in the
treatment and evaluation of patients with MI. Bergelson & Tommaso (1995) studied the
differences in the clinical evaluation and treatment between men and women who
presented with CHD. Their results indicated that women hospitalized with a coronary
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diagnosis were less likely to undergo coronary arteriography than men. They further
concluded that subjective interpretation of the symptoms and conditions prevented
women from having coronary arteriography. Women who did undergo cardiac
arteriography were more likely to be older. The latter finding was supported by Dellborg
and Swedberg (1993) who noted that coronary angiography was performed more often in
men than women during hospitalization. They concluded that women were older when
referred for cardiac catheterization, coronary angioplasty, or coronary artery bypass
surgery. Pharmacologic treatment for patients with MI was also given significantly less
often in women than in men.
In light of these issues, the need for further investigation on the differing
symptoms of MI, treatment, and outcome in men and women is imperative. Mallory
(1997) stated that if symptoms of MI remain unrecognized, patients may delay seeking
medical treatment, and this could complicate their condition, possibly contributing to
congestive heart failure.
Significance of the problem
It is of the utmost importance to educate nurses and other health care
professionals as well as the public regarding the possible existence of gender differences
in the presenting symptoms, treatment, and outcome in MI. Failure to recognize gender
differences in the symptoms of MI can contribute to a delay in treatment and a higher
mortality in women. Nurses play an important role in promoting health and in preventing
and detecting diseases. The recognition of the signs and symptoms of patients with MI is
imperative so that prompt and proper intervention, treatment, and management will be
provided.
Purpose of the study
There are three purposes of this study. These are a) to compare the presenting
symptoms of women and men who were diagnosed with MI in a county hospital in the
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Southwest area of the United States b) to compare the treatments received by women and
men with MI in the emergency department and c) to compare the outcome between
women and men who were diagnosed with MI during hospitalization.

CHAPTER II

REVIEW OF RELEVANT LITERATURE

Introduction
The literature on gender differences in presenting symptoms of myocardial
infarction (MI) is quite sparse. These studies have not addressed the impact of gender
differences in presenting symptoms on treatment and outcome of MI. Recent studies have
focused on gender differences in treatment, management, and mortality of MI. This
literature review addresses research studies and provides rationale and support for the
present study. This chapter addresses coronary heart disease and the presenting symptoms
of MI in general; impact of MI on women; gender differences in the presentation,
treatment, management, and mortality of MI. The latter portion of the chapter identifies
gaps in the literature and will provide a summary of the chapter.

Coronary Heart Disease
Since 1900, cardiovascular disease has been the leading cause of death each year
in America (American Heart Association, 1999). One form of cardiovascular disease that
leads to MI is coronary heart disease. Coronary heart disease (CHD) is caused by
atherosclerosis, a narrowing of the vessel, due to the formation of lipid-laden lesions of
the coronary arteries (McCance & Huether, 1998). This contributes to the interference of
blood flow to the heart and can eventually result in MI, what is commonly known as a
heart attack.
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Myocardial Infarction
Myocardial infarction results from CHD – blood vessel disease in the heart
(American Heart Association, 1999). This definition of MI by the American Heart
Association, a national organization for cardiovascular diseases and stroke, is commonly
accepted and utilized in the literature. McCance and Huether (1998) define MI as the end
point of CHD. MI occurs when there is prolonged ischemia to the heart muscle causing
irreversible cellular death (Lewis & Collier, 1992). The diagnosis of MI depends on the
physiological symptoms, presence of electrographic changes, and elevated cardiac
enzymes.
Presenting Symptoms of Myocardial Infarction
The presenting symptoms of MI vary widely. The American Heart Association
(1999) reports the signs and symptoms of MI with no distinction between women and
men. These are uncomfortable pressure, fullness, squeezing, or pain in the center of the
chest, pain that spreads to shoulders neck or arms, chest discomfort with lightheadedness,
fainting, sweating, nausea, or shortness of breath. McCance and Huether (1998) describe
the common symptoms of MI as chest pain that is heavy or crushing, chest pain with
nausea and/or vomiting, diaphoresis, shortness of breath, or radiation to neck, jaw, back,
or left-arm. Patients may complain of a feeling of weakness, severe indigestion, shortness
of breath, or chest discomfort (Lewis & Collier, 1992). Others may complain of chest
pain lasting more than twenty minutes and not relieved by nitroglycerin or rest, and it is
characterized as deep, unrelenting pressure, ache, and squeezing sensation with nausea
and/or vomiting, and diaphoresis (Fruth, 1991).
Myocardial Infarction in Women
Knowledge about the natural history of CHD in women was limited until recent
years (Thomas & Braus, 1998). More women are dying of heart disease than from breast
or lung cancers (American Heart Association, 1999). The mortality rate in women
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following MI continues to be greater than for men. Marrugat et al. (1998) investigated the
mortality in women following their first MI. A sample of 331 women and 1,129 men
diagnosed with first MI, from 1992 through 1994, in four teaching hospitals in
northeastern Spain was studied. They concluded that older women had more lethal and
severe first MIs. The 28-day mortality rates were significantly higher among women
(18% for women, 8.3% for men; p < .001). The 6-month mortality rates were 25% in
women and 10.8% in men with a significant level of < .001. A recent study was
conducted by Vaccarino, et al., (1999). A sample of 384,878 subjects (n = 155,565
women, n = 229,313 men) who were enrolled in the National Registry of Myocardial
Infarction Two (NRMI2) between the years of 1994 and 1998 was utilized in the study.
The mortality rates were examined according to age group. They reported that younger
women have higher rates of death after MI. The mortality rate during hospitalization was
16.7% among women and 11.5% among men. The mortality rate for women less than 50
years of age was more than twice as high than for men with a significant level of <. 001.
The diagnosis of MI secondary to CHD presents a greater challenge in women.
Recent evidence shows that women present different symptoms of MI. Perhaps this
accounts for the less aggressive treatment received by women in the emergency
departments who present with atypical symptoms of MI. A study was made to test this
hypothesis. Heston et al. (1992) studied the evaluation and management of 445 patients
(n = 246 women, n = 199 men) in ten emergency departments in St. Louis all of whom
presented with acute chest pain. A record review was utilized in the study. Chi-square
and t-tests indicated that men were initially evaluated by the physicians in the emergency
department 30 minutes faster than women. Also, the initial electrocardiogram was
performed 30 minutes earlier for men than for women. Steingart et al. (1991) investigated
the management approach used with women who had MI. A sample of 389 women and
1,842 men was utilized in the study. They found that physicians pursue a less aggressive
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approach in treating women with MI despite their increased cardiac disability. This study
shows that emergency department physicians did not diagnose women as quickly as men
who presented with symptoms of MI, thereby delaying appropriate and early medical
intervention critical to their successful treatment and outcome.
Gender Differences in the Presentation of MI
Recent studies show the presence of gender differences in the clinical presentation
of MI. Micevski (1996) studied the differences in the presenting symptoms of MI in 115
men and 115 women. Chi-square and t-tests showed that chest pain was the common
symptom reported by both men and women. Men presented more often than women with
diaphoresis (p < .0001) and with complaints of right arm pain (p < .03); whereas, women
presented more frequently with back pain/discomfort (p = .01). The limitation of this
study was the use of a small sample population.
A study conducted by Penque et al. (1998) also examined the differences in
presenting signs and symptoms of MI on 98 patients (n = 51 women, n = 47 men).
Structured interviews and chart audits were utilized in the study. Using descriptive
statistics and chi-square analysis, they found existing differences between women and
men. Women were more likely to present with back pain, paroxysmal dyspnea, and loss
of appetite than men. The limitations of their study were the use of convenience sampling
and again, a small sample.
Meischke, Larsen, and Eisenberg (1998) investigated gender differences in acute
myocardial infarction symptom presentation. A sample consisted of 4,497 patients (n =
1,527 women, n = 2,970 men) diagnosed with acute myocardial infaction.These patients
were consecutively included in the study. Their findings showed that gender differences
in symptom presentation do exist. A chi-square analysis indicated that men reported chest
pain and diaphoresis more often than women. Women reported more shortness of breath,
nausea, and vomiting than men. The weaknesses of this study are the method used for
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coding of symptoms and the unequal sampling of women and men with MI.
Gender Differences in Treatment and Management of MI
Recent studies show women and men who present with MI are treated and
managed differently. Women were less likely to be referred for coronary angiography,
percutaneous transluminal coronary angioplasty (PTCA), and coronary arterby bypass
graft (CABG). Steingart et al. (1991) examined the difference in the management of
coronary artery disease between men and women. A total of 2,231 subjects (n = 389
women, n = 1,842 men) with acute myocardial infarction were enrolled in the Survival
and Ventricular Enlargement (SAVE) study. The SAVE trial was conducted at 112
hospitals in the United States and Canada. Patients were enrolled in the study from
January 1987 to January 1990. Chi-square analysis and multiple logistic regression
showed that women were less likely to be referred for cardiac catheterization than men.
Also, women underwent CABG less often than men. The study was conducted in more
than one hospital and had a large sample population. These latter factors give strength to
the study findings. Dellborg and Swedberg (1993) did a similar study. They examined the
difference in treatment between men (n = 1,022) and women (n = 493) with MI. The ttest results showed that coronary angiography was performed significantly more often in
men than in women (p < 0.001).
Research studies documented issues regarding coronary revascularization
between men and women. Women who are referred for coronary revascularization such
as PTCA and CABG tend to be older and sicker (Eysman & Douglas, 1993). Khan, et al.
(1990) investigated the differences in referral for CABG between men and women. A
total of 2,297 patients (n = 482 women, n = 1,815 men) were consecutively selected in
the study. Data were collected using chart review. Two-sample t-tests and chi-square
analysis indicated that women were referred for CABG later in the course of their disease
than men. Women were significantly older than men (68.2 compared with 64.0 years, p <
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0.001). A limitation is that the authors did not examine the course and outcome of women
and men who were not referred for CABG.
Maynard et al. (1992) examined the differences in treatment and outcome of acute
myocardial infarction in 4,891 patients (n =1,659 women; n = 3,232 men) in the Seattle
metropolitan area between the years of 1988 and 1990. A record review was utilized in
the study. Chi-square and t- test analyses showed that women were less likely to undergo
cardiac catheterization, to have PTCA, or to have CABG than men.
Gender Differences in Evaluation for MI
As mentioned previously, Heston et al. (1992) studied the evaluation and
management of 246 women and 199 men in ten emergency departments. They reported
that women were evaluated and managed less aggressively than men. Their findings
indicated that men were seen and assessed by emergency department physicians 30
minutes faster than women.
Gender Differences in Pharmacological Treatment
The issue of gender bias in pharmacological treatment of MI in women and men
has also been investigated. Dellborg and Swedberg (1993) examined a total of 1,515
patients (n = 493 women, n = 1,022 men) diagnosed with MI in a community hospital in
Sweden between 1989-1991. Using the t-test, they found that men were more likely to
receive thrombolytic drugs (34% vs 24%), intravenous nitroglycerin (41% vs 33%), and
intravenous betablockers (36% vs 27%) than women. However, inotropic drugs such as
dobutamine and dopamine were given more often to women (14% vs 8%) than to men.
Ryan et al. (1996) reported that early administration of thrombolytic therapy on
patients with AMI results in improved left ventricular systolic function and survival.
However, gender differences occur in the administration of thrombolytic therapy.
Yarzebski et al. (1996) conducted a study on thrombolytic therapy on 1,680 men and
1,205 women with confirmed acute MI. Data were collected from 16 hospitals in 1986,
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1988, 1990, and 1991. Their findings showed that thrombolytic use in men increased by
127% from 1986 to 1991 and continued to increase after that period. In contrast,
thrombolytic use in women increased from 3.2 % in 1986, 12.8% in 1988, 22.2 % in
1990, and then declined to 19.0 % in 1991 and did not increase further.
Gender Differences in Mortality
In addition to treatment differences, there is also documentation of increased
mortality for women compared to men with MI. As mentioned previously, Khan et al.
(1990) studied in-hospital mortality rates for women (n = 482) and men (n = 1,815) who
had CABG. The findings of the study showed that women had higher mortality rates than
men following CABG (4.6 % for women and 2.6 % for men). Maynard et al. (1992) also
investigated this issue on 4,891 patients (n = 1,659 women and 3,232 men). They
reported that hospital mortality after CABG was higher for women than for men (16 %
for women and 11 % for men before age adjustment). These authors reported that even
after age adjustment, the risk of hospital mortality following CABG was still higher for
women.
Vacarrino et al. (1998) studied the impact of gender and age with respect to shortterm mortality after MI. They found that the mortality rate of women who were younger
than 75 years old was twice than that of men in the same age group. No differences were
found in mortality between women and men who were over 79 years of age following
MI. A weakness of this study is its small sample size of 52 women and 45 men. A more
recent study conducted by Vaccarino et al. (1999) investigated differences in early
mortality after MI in men and women. This study utilized a large sample consisting of
384,878 subjects who had experienced MI (n = 155,565 women, n = 229,313 men). The
study was conducted between 1994 and 1998. Using bivariate analyses, the study
findings were similar to the authors’ previous study. The overall mortality rate during
hospitalization was higher among women (16.7 %) than among men (11.5 %). These
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researchers reported that the mortality of women younger than 50 years of age was more
than twice that for men. This research reveals that not only older women have higher
mortality rates following MI, but also younger women have significantly higher mortality
rates than men.
A recent study conducted by Hochman et al. (1999) examined gender differences
in presentation and outcome on 12,142 patients (n = 3,662 women, n = 8,480 men) with
acute coronary syndromes. Multivariate logistic regression and chi-square tests showed
that women had more complications than men during hospitalization and a significantly
higher mortality rate (p <.001) than men at 30 days (6% vs 4%).

Gaps in the Literature
A review of the literature indicates that there are only a few recent studies that
address gender differences in the presenting symptoms, treatment, and outcome of MI.
These studies utilized small or uneven sample population and did not address whether the
differences in the presenting symptoms of MI in men and women have an impact on the
treatment and outcome. Additional studies on gender differences in presenting symptoms,
treatment, and outcome of MI would add credibility to the existing literature.

Summary
The review of the literature demonstrates that CHD is the leading cause of death
in women and in men (American Heart Association, 1999). Studies on the presenting
symptoms of MI between women and men were reviewed. The American Heart
Association (1999), McCance & Huether (1998), Lewis & Collier (1992), and Fruth
(1991) reported the signs and symptoms of MI with no distinction between women and
men. In contrast, Micevski (1990); Penque et al. (1998); and Meischke et al. (1998)
reported the presence of gender differences in the presenting symptoms of MI. They

13
noted that women presented with backpain, dyspnea, loss of appetite, nausea, and
vomiting; whereas, men presented more often with diaphoresis, complaints of right arm
pain, and chest pain. The need for further research on the differences in symptoms of MI
has been noted.
Studies on the differences in treatment for MI between women and men have also
been reviewed. Numerous studies have been noted regarding gender bias in coronary
revascularization between women and men. Hsia (1993), Steingart et al. (1991), Dellborg
& Swedberg (1993), and Maynard et al. (1992) reported that women were less likely to
be referred for coronary angiography than men; women underwent PTCA and CABG less
often than men. Dellborg & Swedberg (1993) and Ryan et al. (1990) noted that not only
coronary revascularization treatment differs in women and men, but also gender bias in
the pharmacological treatment was also noted. Men were more likely to receive
thrombolytic drugs, nitroglycerin, and betablockers than women.
Studies on gender differences in patients’ outcome with MI during hospitalization
were also discussed. Khan et al. (1990) and Maynard et al. (1990) reported that women
had higher hospital mortality rates than men following CABG. Women had more
complications and had higher mortality rates than men following MI as reported by
Vacarrino et al. (1998) and Hochman et al. (1999). A more recent study by Vacarrino et
al. (1999) was also reviewed. They noted that not only older women have higher
mortality rates following MI, but also younger women have significantly higher mortality
rates than men.

CHAPTER III

FRAMEWORK

Introduction
This study utilizes the Neuman’s Systems Model. This conceptual model has a
wholistic focus and is ideal for guiding this study. The two major concepts of the
Neuman’s Systems Model are stressors and the reactions to such stressors. According to
Neuman (1995), the person has a certain “degree of reaction” to any given stressor at any
given time. This conceptual model, developed by Dr. Betty Neuman in 1972, is presently
recognized and frequently used within the discipline of nursing. This chapter discusses
the conceptual framework, application of the Neuman Systems Model, propositions,
hypotheses, variables of the study, definition of variables, and concludes with a chapter
summary.

Conceptual Framework
In the Neuman’s Systems Model, the client or client system (patient) is viewed as
multidimensional and wholistic. The client is composed of five simultaneously
interacting variables. These variables are physiological, psychological, sociocultural,
developmental, and spiritual factors. The client is represented by a series of broken rings
surrounding the basic core structure (Neuman, 1995). The basic core structure consists of
all survival factors and is protected by the flexible line of defense and the lines of
resistance. (See Figure 1). These lines of resistance surround the core structure and serve
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as a protective mechanism for the client system’s integrity. The client’s usual state is
represented by a solid line called the normal line of defense. The lines of resistance are
activated when the normal line of defense is disrupted by environmental stressors, such as
MI, which causes irreversible damage to the heart muscle. When the normal line of
defense is disrupted, reactions (symptoms) occur such as chest pain or nausea /and
vomiting. Neuman (1995) identifies the flexible line of defense as dynamic, and it serves
as a protective buffer for preventing stressors from penetrating the normal line of defense.
Environment is defined as “all internal and external factors or influences
surrounding the identified client or client system” (p.30). According to Neuman (1995),
the client may be influenced either positively or negatively by environmental forces.
These environmental forces are called stressors, and they can penetrate the flexible and
normal lines of defense. Stressors are classified as intrapersonal, interpersonal, and
extrapersonal. Many environmental factors contribute to the development of MI, such as
a high cholesterol diet or a stressful job. Myocardial infarction is an example of
intrapersonal stressor. Information regarding the symptoms of MI shared by the nurses to
the patients is an example of an interpersonal stressor. Loss of a job due to physical
disability secondary to MI is an example of extrapersonal stressor.
Health is a state of optimal wellness or system stability (Neuman, 1995). Optimal
wellness or stability indicates that all a person’s needs are being met. According to
Neuman, optimal wellness is the condition in which all five variables are in harmony
with the whole system, which determines the resistance of a person to any stressor.
Nursing is concerned with all variables affecting the patient’s response to stress.
Nursing interventions focus on primary, secondary, and tertiary preventions (Neuman,
1995). According to Neuman (1995), these three levels of prevention are important to the
patient prior to, during, and following the event of MI. (See Figure 1). A patient with MI
may also require an intervention in all three areas of prevention simultaneously.
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As illustrated in Figure 1, the goal of primary prevention is to strengthen the
patient’s flexible line of defense and to protect the normal line of defense or usual state.
This is accomplished by educating the health care professionals and the public based on
the findings of this study. The goal of secondary prevention is to strengthen the lines of
resistance by providing appropriate treatment of symptoms to all patients with MI in
order to attain optimal wellness and stability. Interventions in secondary prevention
require prompt assessment that includes recognizing the different symptoms of MI in
men and women and providing appropriate treatment. “If secondary prevention as
intervention fails to reconstitute the patient, death occurs as a result of failure of the basic
structure to support the intervention” (p.34). Tertiary prevention is used for wellness
maintenance. The goal of tertiary prevention is “to maintain an optimal wellness level”
(Neuman, 1995). Educating patients who have had MI regarding the symptoms of the
disease, lifestyle changes that will prevent or reduce their chance of having a second MI,
and cardiac rehabilitation, following MI are examples of tertiary prevention.
Application of the Neuman Systems Model
MI is a stressor that affects the patient’s physiological, psychological,
sociocultural, developmental, and spiritual being; causing system instability. The
patient’s flexible and normal lines of defense have been disrupted by MI as manifested by
their presenting symptoms (stress reaction) such as chest pain; nausea; shortness of
breath; diaphoresis; and chest pain with radiation to jaw, neck, arms, shoulders, and back;
the presence of electrographic changes; and elevated cardiac enzyme levels. (See Figure
2). Recognition of symptoms and treatment of MI will stabilize the patients
physiologically and psychologically, thus preventing a negative impact on their
sociocultural, developmental, and spiritual beings.
Nurses and other health practitioners need to recognize the differing symptoms of
women and men who are experiencing MI so that faster and more appropriate treatment
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will be provided. Treatment of symptoms such as “immediately giving oxygen,
sublingual nitroglycerin, analgesia, and aspirin will improve the patient’s left ventricular
systolic function and survival ” (Ryan et al., 1996). If symptoms are recognized, and if
appropriate treatments and procedures are provided, patients are protected from further
illness or death.

Propositions
The present study proposes that women and men respond to the stressors of MI
differently. This study also proposes that gender differences exist in treatment and
outcome of MI. Because the differences in presenting symptoms of MI can affect the
treament and outcome of patients, this research proposes that the recognition of the
different responses to stressors in women and men with MI can lead to a faster and more
appropriate treatment. These factors can influence the high mortality rates in women.

Hypotheses
The following hypotheses direct this study.
1. There is a gender difference in the presenting symptoms of patients with MI in
the emergency department.
2. There is a gender difference in the cardiac enzyme levels and electrographic
changes on patients with MI who present to the emergency department.
3. There is a gender difference in the mean age of patients who experience their
first MI.
4. There is a gender difference in the treatment received by patients with MI in the
emergency department.
5. There is a gender difference in the outcome of patients with MI during
hospitalization.
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6. There is a gender difference in the coronary diagnostic and therapeutic
procedures on patients with MI during hospitalization.

Definitions of Variables
The following definitions are used in the study for the selected variables.
Myocardial Infarction
The conceptual definition of MI is “prolonged ischemia to the heart muscle
causing irrevesible cellular death” (Lewis & Collier, 1992). The operational definition of
MI is the discharge diagnosis of MI on the patient’s chart.
Gender
Conceptually, gender is defined as a person’s sex. Operationally, gender is the
recorded letter (M for male, F for female) for the subject in the study.
Cardiac Enzymes
Conceptually, cardiac enzymes are the enzymes contained within the heart muscle
cells that are released when the heart muscle is damaged (Pagana & Pagana, 1990). The
operational definition of cardiac enzymes is the documented results of CKMB fractions
greater than 4 ng/dL for both men and women as recorded in the laboratory results
section of the patient’s chart. CKMB values are based on the facility’s protocol where the
study was conducted.
Electrocardiographic Changes
Conceptually, electrocardiographic changes are the changes in the electrical
activity of the heart. The operational definition of electrographic changes is the
documented evidence of pathologic Q wave, changes in ST segments, or changes in T
waves as recorded in the patient’s chart by the emergency department physician.
Presenting Symptom
Conceptually, the presenting symptom is the symptom that causes the individual
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to seek medical attention and that leads to a diagnosis of MI (Micevski, 1996).
Operationally, presenting symptoms are the symptoms of MI described by the American
Heart Association (1999) such as uncomfortable pressure, fullness, squeezing, or pain in
the center of the chest, pain that spreads to shoulders, neck, or arms, chest discomfort
with lightheadedness, fainting, sweating, nausea, or shortness of breath. Presenting
symptoms as described by Micevski (1996) include intrascapular pain, jaw pain, back
pain or discomfort, abdominal pain or discomfort (Micevski, 1996)).
Treatment
The conceptual definition of treatment is the intervention provided to patients at
presentation for treatment of MI in the emergency department to attain system stability or
wellnes and energy conservation (Neuman, 1995). The operational definition of treatment
is the documented use of oxygen, aspirin, nitrates, morphine sulfate, thrombolytics,
heparin, beta-blockers, and ace inhibitors on patients experiencing an MI.These are
recorded in the emergency department sheet, nurses’ notes, and physician’s order sheet.
Outcome
The conceptual definition of outcome is the result or effect of an event (Ehrlich et
al., 1980). The operational definition of outcome is the documented length of stay in the
hospital or death.
Coronary Diagnostic and Therapeutic Procedures
The conceptual definition of coronary diagnostic and therapeutic procedures is the
intervention provided to patients with MI during hospitalization. Operationally, coronary
diagnostic and therapeutic procedures are coronary angiogram, percutaneous transluminal
coronary angioplasty (PTCA), and coronary artery bypass garft (CABG) as documented
in the physician’s progress notes, history and physical sheet, and nurse’s notes.
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Summary
This chapter presented the Neuman’s Systems Model. This nursing model served
as the conceptual framework for this study. Application of the Neuman Systems Model to
the present study, propositions of the study, and the six hypotheses were addressed. The
chapter concluded with the definition of variables.

CHAPTER IV

METHODS AND PROCEDURES

Introduction
The purposes of this study are three fold a) to compare the presenting symptoms
of women and men who are diagnosed with MI b) to compare the treatments received by
women to those received by men who were diagnosed with MI in the emergency
department and c) to compare the difference in outcome of women and men during
hospitalization. This chapter includes a discussion of the research design, study sample,
measurement strategies, data collection procedure, and statistical analyses.

Research Design
The research design that was utilized in this research study is comparative
descriptive design. This particular design was appropriate for the study because the
characteristics of the subjects were described but were not manipulated by the researcher.
Further, there was no research treatment or intervention involved in the study, no
causality examined; and the differences in variables (presenting symptoms of MI and
treatments) between the two groups (women and men) were investigated.

Sample
The target population in this study encompassed both women and men diagnosed
with MI. The accessible population consisted of women and men with a confirmed
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diagnosis of MI who were admitted to a county hospital in the Southwest area of the
United States during the years of 1998-2000.
The sampling criteria included women and men admitted in the emergency
department via ambulance or through the emergency department’s triage area to rule out
MI or unstable angina and who had a discharge or final diagnosis of MI. Other criteria for
the study included patients between the ages of 35 to 65 years old and who had their first
MI. Patients who died in the hospital following MI were also included in the study.
Patients who have had a previous MI were excluded from the study. Based on the
information obtained from the facility’s medical records department where the study was
conducted, the age range for the majority of patients who have their first MI is between
35-65 years old. Patients over 65 years old were excluded in this study because they tend
to have other accompanying diseases that may have an influence on MI.
Power analysis was used to estimate the study’s sample size. To control for Type
II error, an 80% power level is desirable (Burns & Grove, 1997). If power is high, it
strengthens the meaning of the findings (Polit, 1996). A sample of 300 patients (n = 150
women, n = 150 men) was needed to achieve a power of .80 with an alpha set at .05 in a
2-tailed test. This number of patients in the sample allowed for a small effect size (Polit,
1996). There was a sufficient number of patients that were included in the study. The
facility where the study was conducted admits approximately 600-700 patients with MI a
year. The subjects in the study were selected randomly by choosing every other subject
from the hospital’s computer listing. The study design was strengthened by this sampling
method.
Permission to conduct this study was obtained from the researcher’s thesis
committee, the Department of Nursing, and the Human Subjects Rights’ Committee for
The University of Nevada, Las Vegas (UNLV). Written approval to conduct the study
was obtained from the facility’s Nursing Administration. The consent forms were

23
approved by the Director of Nursing, the Director of Staff Development, and the Director
of Health and Information Systems and was submitted to the UNLV’s Human Subjects
Rights’ Committee. To ensure patient confidentiality, patients’ names were not used in
the present study; letters and number codes were used instead. (See Appendix D).

Measurement Strategies
The Gender MI Data Collection Tool (GMIDCT) was compiled by the author to
collect data in the present study. The GMIDCT consists of four sections: demographics,
cardiac markers, presenting symptoms, and treatment received. (See Appendix C).
Demographics:
The first part of the GMIDCT are the demographics. This includes the patient’s
identification code, gender, date of admission, date of discharge, age, and death.
Cardiac Markers:
This is the second part of the GMIDCT. Cardiac markers include electrographic
changes and cardiac enzymes. The electrographic changes are measured by the presence
or absence of Q wave changes, ST segment changes, and T wave changes. Cardiac
markers include the recorded value of CKMB fraction. CKMB values are based on the
facility’s protocol where the study was conducted.
Presenting Symptoms:
The third part of the GMIDCT is the presenting symptoms of MI. The
presenting symptoms include uncomfortable pressure, fullness, squeezing, pain in the
center of the chest, pain spreading to shoulders, pain in the neck, pain in right arm, pain
in left arm, nausea, sweating, shortness of breath, fainting, chest discomfort with
lightheadedness, intrascapular pain, right jaw pain, left jaw pain, mid upper back
pain/discomfort, lower back pain/discomfort, and abdominal pain/discomfort.
This section of the data collection tool is based on Micevski’s (1996) Presenting
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Symptoms’ Data Collection Tool for MI and Mallory’s (1997) American Heart
Descriptors of MI. Consent has been obtained from the authors to use these tools (See
Appendix D). Micevski’s (1996) data collection tool demonstrated content-related
validity and Mallory’s (1997) data collection tool demonstrated inter-rater reliability.
Treatment Received
The fourth part of the GMIDCT is the treatment received or not received by
women and men experiencing MI in the emergency department. This includes oxygen,
aspirin, nitrates, morphine sulfate, thrombolytics, heparin, betablockers, and ace
inhibitors. Interviews with four practicing emergency department physicians confirmed
that these treatments are most commonly given in the emergency department for MI
patients. In addition, these treatments are based on the most recent national guidelines for
the management of patients with acute myocardial infarction as developed by the
American College of Cardiology/American Heart Association’s Task Force Committee
on Management of Acute MI (Ryan et al., 1996).
Coronary Diagnostic and Therapeutic Procedures
The fifth part of the GMIDCT is the coronary diagnostic and therapeutic
procedures received by patients with MI. The coronary diagnostic and therapeutic
procedures include coronary angiogram, PTCA, and CABG.
The GMIDCT was reviewed by one cardiologist, four practicing emergency
department physicians, and one clinical nurse specialist, with a specialty in cardiology.

Procedure for Data Collection
The researcher reviewed the randomly selected patients’ charts in the hospital’s
medical records department. Records from January 1, 1998 to July 1, 2000 were
examined. The following procedures were used for data collection. First, patient
information was entered in the hospital’s computer by the medical records’ supervisor.
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Information that was entered in the computer included patient’s medical diagnosis, using
the number code for MI; gender; age; date of admission; and date of discharge. Second,
upon entering the information, the medical records’ supervisor obtained a computer
printout, which she then gave to the researcher. Third, the researcher randomly selected
the patients by choosing every other subject from the hospital’s computer printout list
until 300 patients (150 women and 150 men) were obtained. The random selection
process began by using a coin flip. The coin head was labeled number 1 and the coin tail
was labeled number 2. The researcher obtained the tail after the coin flip, the count
started on patient number 2. The reseacher then chose every other subject from the
computer printout list until 300 subjects (150 women and 150 men) were obtained.
Fourth, after random selection, the researcher coordinated with the medical records’ staff
to obtain patients’charts. Fifth, the charts retrieved by the medical records’ staff were
given to the researcher to be examined.
A total of twenty charts a day were reviewed. No more than twenty charts were
examined at a time to decrease error in data collection. A research assistant was utilized
to assist with data collection. This research assistant was a licensed registered nurse who
had a specialty in cardiology and who had a background in research study. Inter-rater
reliability was established by having the research assistant read the same charts (10
charts) that the researcher had already examined to ensure the information obtained from
the charts was correct.
The demographics were collected from the patient’s chart as listed on the
paramedic’s sheet, history and physical sheet, and hospital’s “face” sheet. Cardiac
enzymes were obtained from the laboratory section of the patient’s chart. Information on
the electrocardiogram was obtained from history and physical sheet or physician’s
progress notes. Presenting symptoms were collected from the history and physical sheet,
nurse’s notes, or physician’s progress notes. Information on treatment received was
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collected from emergency department sheet, physician’s order sheet, and nurse’s notes.

Statistical Analyses
Hypotheses
The following hypotheses provided a direction for the analysis of study data.
1. There is a gender difference in the presenting symptoms of patients with MI in
the emergency department.
Frequency distributions and chi-square analysis were used for hypothesis one.
Frequency distributions organize the data allowing for examination. Further, they are
used to examine errors in coding and computer programming (Burns & Grove, 1997). By
using frequency distribution, the researcher was able to identify which symptoms of MI
occured most often in men and women, which symptoms were common to both groups,
who had more symptoms, and how many subjects there were in total. Before analyzing
the data, it was checked for error using frequency command in the Statistical Package for
the Social Sciences (SPSS) program. Chi-square analysis was appropriate for this
hypothesis because the data were categorical (nominal level). Chi-square tests for the
differences in frequencies of observed data and compares them with the expected
frequencies (Burns & Grove, 1997). The presenting symptoms were listed as present or
not present. The observed frequencies in each group were compared with the frequencies
expected. A critical value and a level of significance (set at .05) was included and was
obtained in order to support that a statistical difference existed between men and women
in their presenting symptoms. A 2 x 2 chi-square table was used.
2. There is a gender difference in the cardiac enzyme levels and electrographic
changes on patients with MI who present to the emergency department.
The t-test for independent groups was chosen for hypothesis two because the
outcome data and cardiac enzyme levels, were at interval level. This test analyzes the
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difference between two means (Polit, 1996). The difference between the means of women
and men were analyzed regarding cardiac enzyme levels. A significance of .05 was
established.
Chi-square analysis was selected for hypothesis two because the data,
electrographic changes, were at nominal level. The electrographic changes were listed as
present or not present. The observed frequencies in each group were compared with the
expected frequencies. A resulting chi-square co-efficient with a .05 level of significance
or less would indicate that a difference exists between women and men in their
electrographic changes.
3. There is a gender difference in the mean age of patients who experience their
first MI.
The t-test analysis was also chosen for hypothesis three. The difference between
the means for each group was analyzed regarding age. A significance level of .05 was
established.
4. There is a gender difference in the treatment received by patients with MI in the
emergency department.
Frequency distribution was appropriate for hypothesis four. This method gave
information on the total number of treatments, types of treatment received by men and
women, and who received the most treatments. Chi-square analysis was also chosen for
hypothesis four because the data were categorical (nominal level data). The treatments
were listed and were measured as given or not given. The frequencies in each group were
compared with the expected frequencies. A resulting chi-square co-efficient with a .05
level of significance or less would indicate that there is a difference between women and
men regarding the treatments they received. Again, a 2 x 2 chi-square was used for each
treatment.
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5. There is a gender difference in the outcome of patients with MI during
hospitalization.
The t-test for independent groups was appropriate for hypothesis five because the
length of days until discharge was at the interval level. A significane of .05 was
established. In addition, a chi-square was computed regarding the outcome of death,
living discharge, and gender.
6. There is a gender difference in the coronary diagnostic and therapeutic
procedures on patients with MI during hospitalization.
Frequency distribution was used for hypothesis six. Again, by using this method,
the researcher was able to identify the total number of coronary diagnostic and
therapeutic procedures, the types of procedure, which procedures were performed more
frequently, which procedures were common to both groups, and who received the
common procedure.
The above mentioned statistical analyses were performed by the researcher on the
computer using the SPSS software. The data was summarized with a discussion of the
results for each hypothesis. The results were presented in tables and figures.

Methodological Limitations
The limitations of this study included the following a) the sample was drawn from
only one hospital in one geographic area which limited its generalizability; b) the
patient’s documented complaints (presenting symptoms) may have been influenced by
the interviewer’s bias prior to or at the time of hospitalization; c) hospital records may
have not reflected actual information.

Summary
This chapter discussed the proposed research design and sampling procedures.
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Measurement strategies, data collection procedures, and proposed data analysis for each
of the six hypotheses were also addressed. The chapter concluded with a discussion of
methodological limitations.

CHAPTER V

DATA ANALYSIS

Introduction
This chapter summarizes the results of the study and its findings. Statistical
analysis used in addressing the six hypotheses which directed this study are presented.
The Statistical Package for the Social Sciences (SPSS) software was the program used to
analyze the study data using frequency distributions, chi-square tests, and t-tests.

Description of Sample
The population sample consisted of 300 patients (N = 300) who were diagnosed
with MI. The sample had equal representation of women (n = 150) and men (n = 150).
Data were collected through chart review in a county hospital in the Southwest area of
the United States from January 1, 1998 to July 1, 2000. The age of the sample population
ranged from 27 to 65 years old. The mean age was 53.7 years old with a standard
deviation of 7.65 years. The median age was 47 years old and the mode was 55 years old.
(See Figure 3).

Reliability Analysis
The data collection tool that was utilized in the present study was compiled by the
author. The Gender MI Data Collection Tool (GMIDCT) is based on Micevski’s (1996)
Presenting Symptom’s Data Collection Tool for MI and Mallory’s (1997) American
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Heart Descriptors of MI. Mallory’s data collection tool demonstrated an inter-rater
reliability of .90.
Inter-rater reliability was established for the GMIDCT by having a research
assistant read a total of ten charts that the researcher had already reviewed and coded. A
comparison of the agreements obtained between the researcher and the research assistant
on the coding form with number of possible agreements was calculated. A score of 97.3%
agreement was obtained. This presented support for inter-rater reliability of the
GMIDCT.

Results of the Hypotheses
The following are the results of analysis pertaining to each hypothesis.
Hypothesis 1
“There is a gender difference in the presenting symptoms of patients with MI in
the emergency department.”
The first hypothesis was analyzed using frequencies. Chest pain was a common
symptom on presentation as well as shortness of breath, sweating, and left arm pain for
both men and women in the emergency department. However, men presented with chest
pain more often than women (92% vs 83.3%). Women tended to present with nausea
more frequently than men (40% vs 30.9%). Women also demonstrated a more frequent
presence of mid upper back pain more often than men (10.7% vs 5.3%). (See Table 1).
To examine the difference of each of the presenting symptoms between men and
women, a chi-square analysis was utilized. The only significant difference in symptoms
between men and women was chest pain (X2 = 5.210, p = .022). The symptoms that are
close to significance were nausea (X2 = 2.859, p = .091) and mid upper back pain (X2 =
2.899, p = .089). (See Table 2).
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Hypothesis 2
“There is a gender difference in the cardiac enzyme levels and electrographic
changes on patients with MI who present to the emergency department.”
The t-test was used to examine the difference between the two groups. The mean
cardiac enzyme level for women was 32.57 with a standard deviation of 72.45. The mean
cardiac enzyme level for men was 42.32 with a standard deviation of 107.76.
No significant difference in the cardiac enzyme levels was indicated between women and
men with MI (t = .920, p = .358). (See Table 3). Mann Whitney U-test was also
performed for hypothesis two. No significant difference was found in the cardiac enzyme
levels between men and women (Z = -1.010, p = .313).
Electrographic changes were analyzed using frequencies. Men presented with Q
wave changes more often than women (21.3% vs 11%). (See Table 4). A chi-square
analysis was computed to examine the difference in electrographic changes between men
and women. The only significant difference in the electrographic changes between men
and women was the Q wave (X2 = 5.488, p = .019). There was no significant differences
in T wave (X2 = .059, p = .807) or ST segment (X2 = .887, p = .346) on the
electrocardiograph. (See Table 5).
Hypothesis 3
“There is a gender difference in the mean age of patients who experience their
first MI.”
T-test results (t = -2.880, p = .004) indicate that there is a significant gender
difference in the mean age of patients who experience their first MI. The mean age for
women was 54.99 years old with a standard deviation of 7.57 years. The mean age for
men was 52.47 years with a standard deviatin of 7.55 years. (See Table 6).
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Hypothesis 4
“There is a gender difference in treatment received by patients with MI in the
emergency department.”
Hypothesis four was analyzed using frequencies. Oxygen, nitrates, heparin,
aspirin, and morphine sulfate were the common treatments given to both genders.
However, men tended to receive morphine sulfate more often than women (47.0% vs
33.3%) in the emergency department. Men also received betablockers more often than
women (24.0% vs 12.7%). Furthermore, men received aspirin more frequently than
women (50.0% vs 40.7%). Nitrates were given to men more frequently than to women
(90.7% vs 84.0%). (See Table 7).
A chi-square analysis was employed to examine the difference in treatment for MI
received by men and women in the emergency department. A significant difference was
found between the two groups. Morphine sulfate and betablockers were given more often
to men than to women (X2 = 6.108, p = .013; X2 = 6.434, p = .011). (See Table 8).
Hypothesis 5
“There is a gender difference in the outcome of patients with MI during
hospitalization.”
Length of stay was analyzed using frequencies and t-test. The average length of
stay for men in the hospital was 6.48 days. The median was 5 days with a standard
deviation of 3.61 days. The maximum length of stay in the hospital for men was 25 days.
The mean length of stay for women was 7.17 days. The median was 5 days with a
standard deviation of 6.09 days. The maximum length of stay for women in the hospital
was 57 days. T-test results indicate that there is no significant difference in the length of
stay between men and women with MI (t = -1.187, p = .236). (See Table 9). A t-test was
re-run after eliminating five outstanding outliers (1 male, 4 females). There was no
significant difference between men and women in regard to their length of stay.
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To examine the difference of men and women who died in the hospital, frequency
distribution and chi-square were employed. Frequencies revealed that 1 male died and 5
females died. (See Table 11). Due to the small number of subjects, chi-square criteria
were not met, but results indicated that there is no significant gender difference (X2 =
2.720, p = .09).
Hypothesis 6
“There is a gender difference in the coronary diagnostic and therapeutic
procedures on patients with MI during hospitalization.”
Frequency distribution and chi-square test were also utilized for the sixth
hypothesis. The results indicated that men received coronary angiogram and coronary
artery bypass graft (CABG) more often than women (91.3%, 21.0% vs 88.7%, 15.3%).
Percutaneous transluminal coronary angioplasty (PTCA) was performed equally in both
genders (53.3% vs 53.3%). There was no significant difference between men and women
in regard to coronary angiogram (p =.441) and CABG (p = .179). (See Table 12).

Other Findings
A chi-square analysis was performed to examine the relationship of chest pain,
morphine sulfate, and gender. Chest pain was a common symptom reported by both
genders. However, men reported chest pain more often than women did. Morphine
sulfate was given more often to men than to women (47.3% vs 33.3%, p = .013). (See
Table 8). Overall, patients who reported chest pain received morphine sulfate more often
than those patients who did not report chest pain (p = .000). Men who reported chest pain
received morphine sulfate more than those men who did not report the symptom of chest
pain in the emergency department (p = .005). Women who reported chest pain received
morphine sulfate three times more often than those women who did not report chest pain
(p = .013). (See Table 13).
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Summary of Findings
This chapter addressed the data analysis of gender differences in the presenting
symptoms, treatment, and outcome of MI. Results of the statistical tests that were utilized
in the present study for each of the six hypotheses were discussed as well as the reliability
of the data collection tool.
The description of the sample was presented. The age of the sample population
ranged from 27 to 65 years old. The mean age of the total sample was 53.7 years old.
Hypothesis one indicated that chest pain, shortness of breath, nausea, and left arm
pain were the most commom symptoms of MI for both men and women in the emergency
department. Men presented with chest pain more often than women (92% vs 83.3%, p =
.022). Hypothesis two conveyed that there was not a significant difference in cardiac
enzyme levels between women and men with MI, but there was a significant difference in
the presence of Q waves between men and women.
The third hypothesis indicated that a gender difference in the mean age of patients
who experience their first MI exists. The mean age for women was 54.99 years and the
mean age for men was 52.47 years (p = .004). Hypothesis four reflected that men
received morphine sulfate more often than women (47.3% vs 33.3%, p = .013).
Betablockers were also given more often to male patients than to female patients (24.0%
vs 12.7%, p = .011).
Hypothesis five reported that the mean length of stay in the hospital for men was
6.48 days, and for women it was 7.17 days. The maximum length of stay for men was 25
days versus 57 days for women. Furthermore, men had less than one percent chance of
dying than women with MI (.7% vs 3.3%). The sixth hypothesis revealed that men
received coronary angiogram and CABG more often than women (91.3%, 21.0% vs
88.0%, 15.3%); however, the result was not significantly different.
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The chapter concluded with a discussion of additional research findings. This
study indicated that patients who reported chest pain received morphine sulfate more
often than those patients who did not report chest pain (p = .000). Men who reported
chest pain received morphine sulfate more than those men who did not report chest pain
(p = .00479). Women who reported chest pain received morphine sulfate three times
more than those women who did not have chest pain (p = .013).

CHAPTER VI

SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS

Introduction
This chapter summarizes the study and discusses the significance of the study
findings related to the six hypotheses and the conceptual framework. The limitations of
the study, conclusions, implications for nursing, and recommendations for further study
are discussed in the latter portion of the chapter.

Summary of the Study
The purposes of this study were to compare the differences in the presenting
symptoms, treatment, and outcome of MI between men and women. The study sample
consisted of 300 patients (N = 300) who were admitted to the emergency department at a
county hospital in the Southwest area of the United States. Data were collected through
chart review from January 1, 1998 to July 1, 2000. Frequency distributions, chi-square,
and t-tests were used to analyze the study data.
The present study found that chest pain, shortness of breath, sweating, and left
arm pain were the most common symptoms on presentation for both men and women.
However, men presented with chest pain more often than women did (92% vs 83.3%, p
=.022). This study also found a difference in the electrographic changes between men and
women. Men had more Q wave changes than their women counterparts (p = .019). There
was no difference in the cardiac enzyme levels between both genders. The present study
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also found that the average age for women who experience their first MI was two and a
half years older than men. The most common treatments given to men and women in the
emergency department were oxygen, nitrates, morphine sulfate, and heparin. A difference
in the treatment between men and women as found in this study was that men received
morphine sulfate and betablockers more often than women. Within this study, there was
no significant difference in the length of stay in the hospital between men and women, no
significant difference in coronary diagnostic and therapeutic procedures, or outcome
between both genders.

Discussion of the Findings
Difference in the Presentation of MI
The four most common symptoms on presentation for both men and women were
chest pain, shortness of breath, sweating, and left arm pain. These findings are in
concordance with those previously reported by Micevki (1996) where chest pain,
shortness of breath, sweating, and left arm pain were the common symptoms presented
by both genders. Penque et al. (1998) also found chest pain and shortness of breath as
commom symptoms of MI in men and women. This indicates that chest pain continues to
be a leading symptom of MI in both genders.
Research studies on the different symptoms of MI experienced by men and
women have been reported (Meischke et al., 1998; Micevski, 1996; Penque et al., 1998).
This study found a significant difference regarding chest pain between men and women
with MI. Ninety two percent of men presented more frequently with chest pain than
83.3% of women. A possible explanation for this could be that a woman’s chest pain
tends to be vaguer than the type of chest pain men experience (Margo & Penque, 1999).
A woman may perceive pressure on the chest as pain; whereas, some health professionals
may dismiss it as a sign of stress. Meischke et al. (1998) support the findings of this
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study. Their study indicates that chest pain is reported more often in men than in women.
However, their study found that women presented with more shortness of breath and
nausea than men, which is not consistent with the findings of the present study. Penque et
al. (1998) found that women reported with back pain, dyspnea, and loss of appetite more
often than men, which is not in agreement with this study. A possible explanation for the
inconsistencies in this study’s findings and with those reported by Meischke et al. (1998),
Micevski (1996), and Penque et al. (1998) could be the quality of documentation by the
individuals assessing the patient upon presentation in the emergency department. Another
explanation could be the presence of gender bias on the part of health care practitioners
who are more likely to interpret women’s complaints of chest pain or other symptoms as
hypochondriacal behaviour (Rankin, 1997). In addition, the information in the chart may
have been transcribed inaccurately (Mallory, 1997).
Difference in the Cardiac Enzyme Levels and Electrographic Changes in MI
A difference in the cardiac enzyme levels between men and women may have an
impact on the treatment and management of MI. This study did not find a significant
difference in the cardiac enzyme levels between men and women. A possible explanation
for this could be that the cardiac enzyme levels after a myocardial infarction change
overtime (Pagana & Pagana, 1990). The time frame for each patient's hospital admission
and laboratory work-up may have been different. Another explanation could be that the
sample of the present study was relatively small. Perhaps a larger population sample is
needed to reflect enzymatic differences, if they exist.
In this study, a difference in the electrographic changes between men and women
who are experiencing MI in the emergency department was noted. Twenty one percent of
men had more Q wave changes than 11.3% of their women counterparts (p = .019). A
possible explanation for the difference in the electrocardiogram between men and women
found in the present study could be that more men may have had a previous MI, or men
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may have had a transmural infarction more often than women. Transmural infarcts (MI
involving the three layers of the myocardium) are large enough to create an inscription of
a Q wave on the electrocardiograph (McCance & Huether, 1998). One of the inclusion
criteria for the present study was to include those patients who had their first MI;
however, information on whether or not the patient had suffered a previous MI or had a
transmural infarction was not always documented in the history and physical sheet or
physician’s progress notes. The result of the present study on gender difference in the
electrographic changes is not consistent with the study of Elhendy et al. (1999). In their
research study, men had more ST-T abnormalities in the electrocardiogram than women
with abnormal myocardial perfusion. The role of testosterone may be responsible for the
difference on the electrographic pattern between men and women. Testosterone has a
direct effect on the configuration and duration of ventricular repolarization (Bidoggia et
al., 2000). Another possible explanation for the gender difference in the electrographic
changes could be the difference in the cardiac anatomy of men and women. Women have
smaller cardiac size and have diminutive coronary arteries (Beery, 1995; Khan et al.,
1990).
Difference in the Mean Age of Patients with MI
A difference in the mean age of patients who experience their first MI was found
in this study. Women were older than men by two and a half years. This finding is
consistent with the study of Marrugat et al. (1998). In their study, women were eight
years older than men who experience their first MI. Thomas and Braus (1998) report that
women develop coronary artery disease later in their life than men. A possible
explanation could be the protective effect of estrogen in women. Until menopause,
women have significantly less coronary heart disease than age-matched males due to the
influence of estrogen on plasma lipoproteins by raising the high density lipoprotein and
lowering the low density lipoprotein cholesterol (Flavell, 1994).
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Difference in the Treatment of MI
This study found that oxygen, nitrates, aspirin, morphine sulfate, and heparin
were the most common treatments given to men and women in the emergency
department. An explanation for this could be the facility’s protocol on the treatment of
MI in which these medications, except heparin, are the treatments given to all patients
who are experiencing MI, unless contraindicated. Gender difference in the management
of patients with MI has also been the issue of current cardiovascular research. A
difference in the treatment given to men and women in the emergency department was
found in this study. Morphine sulfate and betablockers were given more often to men
than women. This result is congruent with previous research studies on the difference in
the treatment given to men and women with MI. Dellborg & Swedberg (1993); Marrugat
et al., (1998) found that men received betablockers, nitroglycerin, and thrombolytics
more frequently than women. In this study, morphine sulfate was administered more
often to men than women. This is perhaps due to the higher frequency of chest pain in
men than in women, as indicated in this study. The American College of
Cardiology/American Heart Association Task Force (ACC/AHA) guidelines for the
management of patients with MI suggest that betablocker therapy should be given to
patients with evolving MI to reduce morbidity and mortality (Ryan et al., 1996).
Although there are no studies that show men benefit more than women from betablocker
therapy, in this study more men received betablockers than women in the emergency
department. There are two possible explanations for this. One reason could be due to the
individual’s physician’s subjective preference for the treatment of MI. Another reason
could be the presence of gender bias as indicated in previous studies (Marrugat et al.,
1998; Yarzebski et al., 1996; Dellborg & Swedberg, 1993; Hsia, 1993).
Difference in the Outcome of MI
The present study found that there were no significant differences in the length of

42
stay in the hospital between men and women. The average length of stay for men was six
days and seven days for women. Previous research shows that mortality in women is
greater than in men during hospitalization following MI and that women who died were
older than men (Marrugat et al., 1998; Vacarrino et al., 1998; Vacarrino et al., 1999; &
Hochman et al., 1999). These findings are congruent with the frequencies found in the
present study. There were more females who died in the hospital than males following
MI (5 vs 1). Further research with a larger population sample and inclusion of older
patients is warranted to determine whether the difference is statistically significant.
Difference in the Coronary Diagnostic and Therapeutic Procedures
In this study, there was no significant difference between men and women in
regard to coronary angiogram, PTCA, and CABG. This finding is in contrast with
previous research studies on gender bias in the management of MI. Men receive coronary
angiogram, PTCA, and CABG more than their women counterparts (Steingart et al.,
1991; Dellborg & Swedberg, 1993; & Maynard et al., 1992). Women are referred for
coronary angiogram, PTCA, and CABG later in the course of their disease (Eysman &
Douglas, 1993; Khan et al., 1990). Again, further research is warranted.
Relationship of Findings to the Neuman Systems Model
The findings of this study support the Neuman’s Systems Model (1995). Stress
and patient response to stress are two major components of this framework. Men and
women’s flexible and normal lines of defenses have been disrupted by MI as manifested
by their presenting symptoms. The study partially supports the fact that there is a
difference between the male and female client system in regard to the stress response
from MI. Chest pain, shortness of breath, sweating, and left arm pain were the most
common stress responses reported by both genders in the present study. However, more
men reported chest pain than women did. Neuman (1995) states that the recognition of
the symptoms and initiation of treatment in the secondary prevention will strengthen the
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patient’s lines of resistance and will prevent system instability or death. In this study, the
common treatments given to men and women who are experiencing MI in the emergency
department were oxygen, morphine sulfate, aspirin, nitrates, and heparin. More men
received morphine sulfate and betablockers than women did. The recognition of the
differing symptoms of men and women who are experiencing MI in secondary prevention
is crucial. If symptoms are accurately recognized and appropriate treatments are
provided, the patient’s lines of resistance will be strengthened, resulting in protection
from further illness or death.

Limitations of the Study
The study results cannot be generalized to the overall population because the
sample was drawn from only one hospital in one geographic area with a relatively small
sample (N = 300). Risk factors for coronary artery disease were not addressed.
A possible limitation of the study regards the information from the patient’s chart.
Data obtained from the patient’s record may have been documented incorrectly or may
have been influenced by the health care professional’s bias prior to or at the time of
hospitalization.
The Gender MI Data Collection Tool (GMIDCT) utilized in this study was
developed by the researcher. Although the tool had an inter-rater reliability score of .97,
it has not been tested in other studies, which possibly limits its reliability and validity for
this study. Further research is needed with the use of the GMIDCT.

Conclusions
In light of the study’s findings and limitations, the following conclusions are
presented for this population:
1. Women experience less chest pain than men during MI.
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2. Men present with Q wave changes more frequently than women with MI.
3. A difference in the treatment of MI exists between men and women. Women
who are experiencing MI receive less morphine sulfate and betablockers than men.
4. Women are older than men when they experience their first MI.
5. Men and women who are hospitalized for MI undergo the same coronary
diagnostic and therapeutic procedures.

Implications for Nursing
Nurses are in the front line of interaction with patients presenting to the
emergency department. Nurses’ knowledge regarding symptomatology of MI and its
treatment and outcome can affect the plan of care for patients.
The findings of this study can help nurses, nurse practitioners, and other health
care providers in the care of MI patients. Health care professionals should be aware that
gender bias in the treatment of MI is a possibility. They should also be cognizant that
men and women may present with multiple or different symptoms of MI. Assessment and
diagnosis of MI is more complex in women than in men, since their presentation patterns
are usually more variable (Rankin, 1997).
Based on the findings of this study, women may not report chest pain when
experiencing MI. If women do not recognize their own presentation of MI as different
from their partners or spouses, they may be less likely to report important clinical
symptoms. Therefore, astute assessment by the nurses and the health care providers is
crucial so that fair and more appropriate treatment will be provided to all patients
experiencing a heart attack without gender bias. To reduce morbidity and mortality in
women with MI, women should be treated exactly the same as men.
Nurses are in excellent position to educate patients and the public. Based on the
findings of this study and those from previous research studies, nurses should educate
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their patients on the symptoms of MI and the gender difference in the symptom
presentation of MI. They should also advocate for more research to benefit the health of
women and men. Although the risk factors for MI were not examined in this study,
nurses should continue to provide routine teaching on their patients for the prevention of
coronary artery disease. This would decrease mortality rates of men and women alike.

Recommendations for Further Study
Recommendations for further research studies are suggested based on the findings
of this study:
1. Replicate the present study using a larger population sample in more than one
hospital and from various geographical regions.
2. Investigate gender difference of MI symptoms using patient questionnaires.
3. Investigate possible differences in the perception of health care providers (such as
emergency room staff nurses, nurse practitioners, physicians, and physician’s
assistants) regarding the presenting symptoms, treatments, and outcome in MI between
male and female patients.
4. Examine women and men regarding their outcome after MI using a five-year
longitudinal study.
5. Compare the pharmacological treatments given to men and women during their
hospitalization following MI in more than one hospital unit (such as in a coronary care
unit and while in an intermediate care unit).
6. Compare the cultural differences between men and women who have experienced
their first MI.
7. Examine women and men for the presence of risk factors for MI.
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Summary
Coronary heart disease continues to be the leading cause of death in men and
women in the United States (American Heart Association, 1999). However, recent studies
show that mortality in women is higher than in men following MI. Although this study
did not show a significant difference in mortality between men and women, we should be
aware that coronary heart disease is still the largest killer of women in the nation
(American Heart Association, 1999). This study has shown that gender differences in the
presentation and treatment of MI exist. Nurses and other health care professionals should
be aware of the difference in the presenting symptoms of MI in men and women and they
should also be alert to the presence of gender bias in the treatment of the disease. A fair
treatment should be provided to both genders to minimize the morbidity and mortality
from MI, especially in women.
Research studies that focus on women’s cardiovascular health continue to be a
challenge in the health care arena. As knowledge about women and heart disease
increases, nurses and other health care professionals will gain new tools to combat and
help prevent heart disease in women (Thomas & Braus, 1998).
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Stressor
MI

FLD= Flexible Line of
Defense
Protects NLD from
stressor

NLD =Normal Line of
Defense
-Client’s Usual or
Wellness State
-Protects Basic Core

LR= Lines of Resistance
Activated when stressors have disrupted
NLD
-Reaction to stressors occurs (symptoms)
-Protects Basic Core

Basic
Core

Primary Prevention
-Education of health care
professionals & public.
This strengthens FLD.

Secondary prevention
-Intervention &
Treatment of Symptoms
This strengthens LR

Tertiary prevention
-Reeducation to prevent
secondary MI
-Maintenance of Stability

Figure 1. Illustration of a patient with MI using the Neuman Systems Model.
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(Stressor)
MI

TREATMENT
Oxygen, Aspirin,
Nitrates, Morphine
Sulfate, Thrombolytics,
Heparin, Beta Blockers,
Ace inhibitors

Women
&
Men

(Response to Stressors)

CORONARY DIAGNOSTIC
& THERAPEUTIC PROCEDURES
Coronary Angiogram
PTCA
CABG

-PRESENTING SYMPTOMS
uncomfortable pressure, fullness,
squeezing, or pain in the center of the
chest, pain that spreads to shoulders,
neck, or arms, chest discomfort with
lightheadedness, fainting, sweating,
nausea, or shortness of breath,
abodominal pain or discomfort, and back
pain or discomfort.
-CARDIAC ENZYME LEVELS
Creatine Kinase, CKMB
-ELECTROGRAPHIC CHANGES
Q wave, ST segment changes, T wave
changes.

Figure 2. Application of the selected variables under study in the Neuman Systems
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Table 1 Frequencies of Age of Patients with MI by Gender (N=300)

Frequencies

Age in Years

Men (n=150)

Women (n=150)

Count Percent

Count Percent

25-30

0

0.0%

1

0.7%

31-36

2

1.3%

2

1.3%

37-42

14

9.3%

8

5.3%

43-48

32 21.3%

17

11.3%

49-54

42 28.0%

31

20.7%

55-60

32 21.3%

48

32.0%

61-65

28 18.7%

43

28.7%
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Table 2 Frequencies of Presenting Symptoms of Patients with MI by Gender (N=300)

Frequencies

Variable

pain in the center of the chest

Men (n=150)

Women (n=150)

Count Percent

Count Percent

138 92.0%

125

83.3%

shortness of breath

72 48.0%

74

49.3%

sweating

62 41.3%

56

37.3%

pain in L arm

60 40.0%

62

41.3%

nausea

46 30.7%

60

40.0%

pain spreading to shoulders

22 14.7%

14

9.3%

pain in the neck

18 12.0%

25

16.7%

pain in R arm

15 10.0%

20

13.3%

uncomfortable pressure

15 10.0%

16

10.7%

mid upper back pain/discomfort

8

5.3%

16

10.7%

lower back pain/discomfort

5

3.3%

9

6.0%

L jaw pain

5

3.3%

8

5.3%
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Table 2 (cont) Frequencies of Presenting Symptoms of Patients with MI by Gender
(N=300)

Frequencies

Variable

Men (n=150)

Women (n=150)

Count Percent

Count Percent

chest discomfort with lightheadedness

5

3.3%

6

4.0%

R jaw pain

4

2.7%

5

3.3%

squeezing

1

0.7%

2

1.3%

abdominal pain/discomfort

0

0.0%

2

1.3%

intrascapular pain

0

0.0%

1

0.7%

fainting

0

0.0%

1

0.7%

fullness

0

0.0%

0

0.0%

41 27.3%

53

35.3%

other (vomiting, dizziness, weakness, cough)
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Table 3 Chi-Square Results of Presenting Symptoms of Patients with MI by Gender
(N=300)

Variable
uncomfortable pressure

2

X Value (df=1)

Level of Significance

0.036

0.850

fullness

a

squeezing

b

1.000

pain in the center of the chest

5.210

0.022

pain spreading to shoulders

2.020

0.155

pain in the neck

1.330

0.249

pain in R arm

0.809

0.369

pain in L arm

0.055

0.814

nausea

2.859

0.091

sweating

0.503

0.478

shortness of breath

0.053

0.817

b

1.000

fainting

a. No statistics are computed because fullness is a constant.
b. Fisher's Exact Test computed because of low expected counts.
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Table 3 (cont) Chi-square Results of Presenting Symptoms of Patients with MI by
Gender (N=300)

Variable

2

X Value (df=1)

Level of Significance

0.094

0.759

intrascapular pain

b

1.000

R jaw pain

b

1.000

L jaw pain

0.724

0.395

mid upper back pain/discomfort

2.899

0.089

lower back pain/discomfort

1.199

0.274

abdominal pain/discomfort

b

0.498

2.231

0.135

chest discomfort with lightheadedness

other (vomiting, dizziness, weakness, cough)

b. Fisher's Exact Test computed because of low expected counts.
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Table 4 T-test Results of Cardiac Enzyme Levels of Patients with MI by Gender
(N=300)

Variable

N

M

SD

Men

150

42.324

107.760

Women

150

32.569

72.455

Variance

t

df

Sig. (2-tailed)

0.920

298

0.358

CK-MB levels

Assumed Equal
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Table 5 Frequencies of Electrographic Changes in Patients with MI by Gender (N=300)

Variable

Q wave changes
ST segment changes
T wave changes

Frequencies
Men (n=150)

Women (n=150)

Count Percent

Count Percent

32 21.3%

17

11.3%

110 73.3%

117

78.0%

52 34.7%

50

33.3%
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Table 6 Chi-Square Results of Electrographic Changes in Patients with MI by Gender
(N=300)

Variable

2

X Value (df=1)

Level of Significance

Q wave changes

5.488

0.019

ST segment changes

0.887

0.346

T wave changes

0.059

0.807
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Table 7 T-test Results of Mean Age of Patients with MI by Gender (N=300)

Variable

N

M

SD

Men

150

52.473

7.547

Women

150

54.987

7.568

Variance

t

df

Sig. (2-tailed)

-2.880

298

0.004

Age

Assumed Equal
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Table 8 Frequencies of Treatment Received by Patients with MI by Gender (N=300)

Frequencies

Variable

Men (n=150)

Women (n=150)

Count Percent

Count Percent

Nitrates

136 90.7%

126

84.0%

Oxygen

132 88.0%

122

81.3%

Heparin

117 78.0%

108

72.0%

Aspirin

76 50.7%

61

40.7%

Morphine Sulfate

71 47.3%

50

33.3%

Thrombolytics

40 26.7%

35

23.3%

Beta blockers

36 24.0%

19

12.7%

0

0.0%

Ace inhibitors

3

2.0%
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Table 9 Chi-Square Results of Treatment in Patients with MI by Gender (N=300)

2

Variable

X Value (df=1)

Level of Significance

Oxygen

2.568

0.109

Aspirin

3.023

0.082

Nitrates

3.013

0.083

Morphine Sulfate

6.108

0.013

Thrombolytics

0.444

0.505

Heparin

1.440

0.230

Beta blockers

6.434

0.011

Ace inhibitors

a

0.247

a. Fisher's Exact Test computed because of low expected counts.
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Table 10 T-test Results of Outcome of Patients with MI by Gender (N=300)

Variable

N

M

SD

Men

150

6.487

3.612

Women

150

7.173

6.094

Variance

t

df

Sig. (2-tailed)

-1.187

298

0.236

Length of Stay

Assumed Equal
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Table 11 Frequencies of Outcome in Patients with MI by Gender (N=300)

Frequencies

Variable

Death

Men (n=150)

Women (n=150)

Count Percent

Count Percent

1

0.7%

5

3.3%
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Table 12 Frequencies of Coronary Diagnostic and Therapeutic Procedures in Patients
with MI by Gender (N=300)

Variable

Coronary Angiogram

Frequencies
Men (n=150)

Women (n=150)

Count Percent

Count Percent

137 91.3%

133

88.7%

PTCA

80 53.3%

80

53.3%

CABG

32 21.3%

23

15.3%
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Table 13 Frequencies and Chi-Square Results of Morphine Sulfate Treatment by Chest
Pain Symptom in Patients with MI by Gender (N=300)

Frequencies

Variable
Received Morphine Sulfate

All subjects (n=121)

Chest Pain

No Chest Pain

Count Percent

Count Percent

117 96.7%

4

3.3%

Men (n=71)

70 98.6%

1

1.4%

Women (n=50)

47 94.0%

3

6.0%

Variable

2

X Value (df=1)

Level of Significance

Received Morphine Sulfate

All subjects

15.285

0.000

Men

7.958

0.005

Women

6.144

0.013

APPENDIX C

GENDER MI DATA COLLECTION TOOL
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The Gender MI Data CollectionTool
I.

Demographics:
1. Identification Code: _________
2. Gender: Male ___ Female ____
3. Date of Admission: __________
4. Date of Discharge: ___________
5. Deceased: ____Yes _____No
6. Age: ____

II.

Cardiac Markers:
1. Electrographic changes: (1=present, 0= not present)
Q wave

____

ST segment changes ____
T wave changes

____

2. Cardiac Enzymes:
____ CKMB fraction
III. Presenting Symptoms: (1=present, 0=not present)
___ uncomfortable pressure
___ fullness
___ squeezing
___ pain in the center of the chest
___ pain spreading to shoulders
___ pain in the neck
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___ pain in R arm
___ pain in L arm
___ nausea
___ sweating
___ shortness of breath
___ fainting
___ chest discomfort with lightheadedness
___ intrascapular pain
___ R jaw pain
___ L jaw pain
___ mid upper back pain/discomfort
___ lower back pain/discomfort
___ abdominal pain/discomfort
___ other
IV.

Treatment Received: (1=received, 0=not received)
___ Oxygen
___ Aspirin
___ Nitrates
___ Morphine Sulfate
___ Thrombolytics
___ Heparin
___ Beta blockers
___ Ace inhibitors

V.
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Coronary Diagnostic and Therapeutic Procedures: (1 = received, 0= not received)
___ Coronary Angiogram
___ PTCA
___ CABG
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